SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 29 of 94
Newsletters
Fortune Connect invites the next generation of business leaders to join our community
By
David Meyer
and
Alan Murray
January 12, 2022
Health
Cannabis compounds stopped COVID virus from infecting human cells in lab study
By
Kanoko Matsuyama
and
Bloomberg
January 12, 2022
Health
European countries are taking wildly different approaches to Omicron’s surge as WHO makes ominous prediction
By
Andrew Marquardt
January 11, 2022
Health
Emergency rooms are at their breaking point with patients waiting for days
By
Dana G. Smith
January 11, 2022
Health
Spain suggests a radical ‘end-demic’ approach to Omicron: Just treat it like the flu
By
Ian Mount
January 11, 2022
Newsletters
Omicron’s effect on the economy is hard to fathom
By
David Meyer
and
Alan Murray
January 11, 2022
Health
Pushback grows against fourth COVID vaccine doses, with experts urging caution over expanding booster campaigns
By
David Meyer
January 11, 2022
International
When will Novavax’s vaccine be ready? CEO Stanley Erck says 10 countries may approve its COVID shot in next 90 days
By
Grady McGregor
January 11, 2022
Health
Pfizer is testing a hybrid COVID vaccine, mixing its original with a new formulation that shields against Omicron
By
Riley Griffin
and
Bloomberg
January 11, 2022
Health
Omicron testing shortages and delays are making results useless—and deepening COVID inequality
By
Sophie Mellor
January 10, 2022
Health
Doctor says we need to take Omicron more seriously after detailing his son’s symptoms
By
Andrew Marquardt
January 10, 2022
Health
Child hospitalization rates reach record highs amid Omicron’s surge
By
Andrew Marquardt
January 10, 2022
Finance
Omicron may be less severe than Delta, but it could hit the global economy even harder in 4 painful ways
By
Bernhard Warner
January 10, 2022
Newsletters
As Germany’s COVID vaccine mandate is delayed, beware anyone who says the issue has easy answers
By
David Meyer
January 10, 2022
Health
Catching the common cold can help fend off COVID, study finds
By
Tim Loh
,
John Lauerman
and
Bloomberg
January 10, 2022
Most Popular
Commentary
My wife sold her engagement ring to pay our tax bill. It led to my PhD and my career tackling the student-debt crisis
By
Brian Walsh
Success
AI expert says it’s ‘not a question’ that AI will take over all jobs—but people will have 80 hours a week of free time
By
Emma Burleigh
Economy
Congressional Budget Office says Trump's immigration crackdown will shrink U.S. population faster than expected, a...
By
Sasha Rogelberg